02/26/2026
Alcanza is honored to be recognized with the 2025 Impact Award from the Healthcare Private Equity Association (HCPEA).
Presented by HCPEA, this award highlights organizations that are driving meaningful progress in healthcare. Owned by member firm Martis Capital, the Alcanza Clinical Research Site Network accelerates the development of new therapies by reducing barriers to clinical research and participation for all.
Carlos E. Orantes, CEO of Alcanza, shares how a focus on the end goal motivates the organization’s team culture: “The biggest success is when we learn of a drug that we had a hand in helping with development make it to the market and ultimately be in the hands of the patient.”
With 25+ fully owned sites, we remain committed to expanding access, advancing inclusive research, and delivering education and clinical trial opportunities on participants’ own terms.
We are grateful to HCPEA for this recognition, and to our integral teams whose dedication to research excellence and life-changing outcomes make this work possible.
